Decera Clinical Education Neuroscience Podcast

Updates on new data and best practices in patient care across a wide variety of psychiatric and neurological illnesses from Decera Clinical Education. Gain a deeper understanding and practical clinical insights on topics ranging from bipolar depression to Parkinson’s disease psychosis. Select episodes available for CME/CE credit.

Decera Clinical Education Neuroscience Podcast is a education podcast hosted by Decera Clinical Education, with 46 episodes on record and a Required Pod Score of 81. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Decera Clinical Education hosts Decera Clinical Education Neuroscience Podcast, a education show with 46 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #49

  Breaking the Therapeutic Ceiling: Emerging Treatments for Schizophrenia Care

  Aug 14, 202649 min

  Emerging therapies are reshaping schizophrenia care by introducing novel mechanisms that extend beyond traditional dopamine receptor blockade. Listen in to learn from Dr Leslie Citrome about evolving concepts in schizophrenia neurobiology; the clinical evidence supporting emerging therapeutic approaches with a focus on muscarinic-targeted therapies; and practical strategies for translating these advances into patient care, including treatment selection, safety, and tolerability considerations. Presenter: Leslie Citrome, MD, MPH Clinical Professor, Psychiatry and Behavioral Sciences New York Medical College Valhalla, New York Adjunct Professor, Psychiatry and Behavioral Sciences Northwestern Feinberg School of Medicine Chicago, Illinois Link to full program: https://bit.ly/4gvLZYm Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

  ListenShow Notes
• 

  Episode #48

  gMG C5 Inhibitors: Matching Therapy to Patient Needs

  Jun 29, 202644 min

  Novel C5 inhibitors are reshaping individualized care for generalized myasthenia gravis. Listen in to learn from Drs Muppidi, Narayanaswami, Kaminski, and Paul about persistent needs in gMG care, clinical differences among C5 inhibitors, and practical considerations for matching treatment decisions to patient goals, access, safety, and long-term adherence. Presenters: Srikanth Muppidi, MD Clinical Professor Department of Neurology and Neurological Sciences Stanford University Stanford, California Pushpa Narayanaswami, MD, FAAN Professor of Clinical Neurology Harvard Medical School Vice Chair, Clinical Operations Department of Neurology Beth Israel Deaconess Medical Center Boston, Massachusetts Henry J. Kaminski, MD Jeffrey Lieberman Professor of Neurosciences Professor of Neurology, Pharmacology & Physiology George Washington University Principal Investigator, MGNet Rare Disease Clinical Research Consortium Washington, DC Pritikanta Paul, MD Assistant Professor of Neurology University of California, San Francisco Co-Director, MG Clinic San Francisco, California Link to full program: https://bit.ly/4aXq3Ce Get access to all of our new podcasts by subscribing to the Decera Clinical Education Neuroscience Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

  ListenShow Notes
• 

  Episode #46

  What’s Next in MS Care: Guidelines & Pipeline

  Mar 18, 202622 minS0

  <p>Multiple sclerosis care is evolving fast, from what current AAN guidance emphasizes to what’s emerging in the treatment pipeline. In this episode, Patricia K. Coyle, MD, FAAN, FANA, reviews practical, patient-centered principles for MS management, including shared decision-making, realistic expectations, adherence, monitoring, and optimizing comorbidities and lifestyle factors. She also explains when to reassess and potentially switch therapy based on relapses, disability progression, and MRI activity, and highlights pipeline advances such as CNS-penetrant BTK inhibitors and other investigational approaches.</p> <p>Presenters:<br>Patricia K. Coyle, MD, FAAN, FANA<br> Distinguished Professor of Neurology<br> Vice Chair for Ac...

  ListenShow Notes
• 

  Episode #47

  Therapy Trends & Tipping Points in MS: A Case-Based Look at High-Risk Disease and Emerging Treatments

  Mar 13, 202617 minS0

  <p>Wondering what is coming next in MS care beyond today’s disease-modifying therapies? This episode spotlights CNS-penetrant oral BTK inhibitors and the fast-moving pipeline targeting neuroinflammation, immune reset, and future CNS repair, then brings it to life with a real patient case that tests treatment selection and the decision to switch therapy. Led by Patricia K. Coyle, MD, FAAN, FANA, it is a practical listen for healthcare professionals who want a clear sense of where MS treatment is heading and why it matters now.</p> <p>Presenters:</p> <p>Patricia K. Coyle, MD, FAAN, FANA<br> Distinguished Professor of Ne...

  ListenShow Notes
• 

  Episode #45

  Smoldering and Spiking: Mapping MS and Modern DMTs

  Mar 11, 202619 minS0

  <p>Multiple sclerosis (MS) is increasingly understood as a spectrum in which relapsing activity and progression can overlap, creating a need for smart, individualized use of disease-modifying therapies. Listen in to learn from Patricia K. Coyle, MD, FAAN, FANA, for a practical review of today’s MS DMT options, with a focus on high-efficacy monoclonal antibodies such as anti-CD20 therapies, how healthcare professionals think about progression concepts like PIRA and RAW, and what emerging trial designs like OCTOPUS may mean for improving treatment options in progressive MS.</p> <p>Presenter:</p> <p>Patricia K. Coyle, MD, FAAN, FANA<br> Distinguished Pr...

  ListenShow Notes

Recent guests on Decera Clinical Education Neuroscience Podcast. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.